Details of the Drug
General Information of Drug (ID: DMC56YJ)
| Drug Name |
GNF-PF-2700
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
5361-37-5; GNF-Pf-2700; N-(8-ethoxy-4-methylquinazolin-2-yl)guanidine; 1-(8-ethoxy-4-methylquinazolin-2-yl)guanidine; CHEMBL602578; N-(8-Ethoxy-4-methyl-quinazolin-2-yl)-guanidine; Guanidine, N-(8-ethoxy-4-methyl-2-quinazolinyl)-; amino(8-ethoxy-4-methylquinazolin-2-yl)carboxamidine; BAS 00364218; 2-(8-ethoxy-4-methylquinazolin-2-yl)guanidine; AC1MDO65; SCHEMBL4104976; MolPort-000-870-551; ZX-AN037437; ALBB-021848; BDBM50322849; STK091313; SBB041931; ZINC19314134; AKOS000270455; MCULE-2552194685; ST4052426; R3533
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 245.28 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||


